eISSN: 2345-6558

Free Access

Journal of Parathyroid Disease 2013;1(1):13-14
Elevated serum parathyroid hormone is a heart risk factor in hemodialysis patients

Epidemiology and Prevention

Hamid Nasri *

1 Department of Nephrology, Division of Nephropathology, Isfahan University of Medical Sciences, Isfahan, Iran


*Corresponding author: Prof. Hamid Nasri,
Email: hamidnasri@med.mui.ac.ir


Notes

Implication for health policy/practice/research/medical education

Patients with end-stage kidney failure generally have cardiovascular diseases too and cardiovascular disease is the most common cause of death in patients on hemodialysis. Secondary hyperparathyroidism is common in patients on hemodialysis and is defined by excessive serum parathyroid hormone level, parathyroid gland hyperplasia and an imbalance in calcium and phosphorus metabolism. In fact parathormone is a main uremic toxin, and may be responsible for long-term outcomes that include severe vascular calcifications, kidney osteodystrophy, immune dysfunction, alterations in heart structure and function, and anemia.These adverse consequences may contribute to an increased risk of cardiovascular mortality and morbidity among end-stage renal failure patients.

Please cite this paper as: Nasri H. Elevated serum parathyroid hormone is a heart risk factor in hemodialysis patients. J Parathyr Dis 2013; 1(1): 13-14.


Comments
First name  
Last name  
Email address  
Comments  
Security code



Article
PDF


Export citation
EndNote
Reference Manager
BibTeX
Medlars
Refworks

Cite by
Google Scholar

Google Scholar
Articles by Hamid Nasri
Similar articles
Related articles

PubMed
Articles by Hamid Nasri


Article Access Statistics
Viewed
PDF Downloaded
Comments

Share this article!
Creative Commons Attribution 4.0 License This work is licensed under a Creative Commons Attribution 4.0 License.
Copyright © 2016 The Author(s)
Published by Nickan Research Institute